Jiangsu Hengrui reported CNY52.04B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Kangmei Pharma CNY 6.8B 225.83M Mar/2026
Sh Fosun Pharma CNY 33.96B 144.01M Mar/2026
Sh Pharmaceutical CNY 180.46B 3.46B Dec/2025
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Wuxi Apptec CNY 65.17B 3.49B Mar/2026
Zz Pientze Pharmaceu CNY 11.43B 728.95M Mar/2026